MY102089A - Antibacterial compounds. - Google Patents

Antibacterial compounds.

Info

Publication number
MY102089A
MY102089A MYPI87002280A MYPI19872280A MY102089A MY 102089 A MY102089 A MY 102089A MY PI87002280 A MYPI87002280 A MY PI87002280A MY PI19872280 A MYPI19872280 A MY PI19872280A MY 102089 A MY102089 A MY 102089A
Authority
MY
Malaysia
Prior art keywords
group
stands
hydrogen atom
compound
antibacterial compounds
Prior art date
Application number
MYPI87002280A
Inventor
Kondo Masahiro
Miyake Akio
Fujino Masahiko
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1984/000270 external-priority patent/WO1985005620A1/en
Priority claimed from PCT/JP1985/000102 external-priority patent/WO1986005184A1/en
Priority claimed from EP85104687A external-priority patent/EP0160252B1/en
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of MY102089A publication Critical patent/MY102089A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A COMPOUND OF THE FORMULA WHEREIN R0 STANDS FOR HYDROGEN ATOM, NITROGEN-CONTAINING HETEROCYCLIC GROUP ACYL GROUP OR ESTERIFIED CARBOXYL GROUP, Z STANDS FOR S, S-O, 013 OR CH2, R4 STANDS FOR HYDROGEN ATOM, METHOXY GROUP OR FORMAMIDO GROUP, R13 STANDS FOR HYDROGEN ATOM, METHYL GROUP, HYDROXYL GROUP OR HALOGEN ATOM AND A STANDS FOR AN OPTIONALLY SUBSTITUTED IMIDAZOL-I-YL GROUP FORMING A CONDENSED RING AT THE 2,3- OR 3,4-POSITION OR A PHYSIOLOGICALLY OR PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER THEREOF. THIS COMPOUND IS NOVEL AND HAS EXCELLENT ANTIBACTERIAL ACTIVITY.
MYPI87002280A 1984-04-23 1987-09-29 Antibacterial compounds. MY102089A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/JP1984/000212 WO1985004879A1 (en) 1984-04-23 1984-04-23 Cephem compounds
PCT/JP1984/000270 WO1985005620A1 (en) 1984-05-25 1984-05-25 Cephem compounds
PCT/JP1985/000102 WO1986005184A1 (en) 1985-03-01 1985-03-01 Antibacterial compound
EP85104687A EP0160252B1 (en) 1984-04-23 1985-04-18 Antibacterial compounds

Publications (1)

Publication Number Publication Date
MY102089A true MY102089A (en) 1992-03-31

Family

ID=13818317

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87002280A MY102089A (en) 1984-04-23 1987-09-29 Antibacterial compounds.

Country Status (6)

Country Link
AT (1) ATE79882T1 (en)
DK (1) DK179985A (en)
HU (1) HU195966B (en)
MY (1) MY102089A (en)
WO (1) WO1985004879A1 (en)
ZA (1) ZA853017B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4496896A (en) * 1995-01-30 1996-08-21 Takeda Chemical Industries Ltd. Cephem compounds, their production and use

Also Published As

Publication number Publication date
HUT40444A (en) 1986-12-28
DK179985A (en) 1985-10-24
HU195966B (en) 1988-08-29
WO1985004879A1 (en) 1985-11-07
ATE79882T1 (en) 1992-09-15
DK179985D0 (en) 1985-04-22
ZA853017B (en) 1986-12-30

Similar Documents

Publication Publication Date Title
GR3005315T3 (en)
ES8704926A1 (en) Benzothiazole and benzothiophene derivatives.
GR3036253T3 (en) Cyclopropyl alkanoic acid derivatives
ES8801289A1 (en) Antibacterial compounds, their production and use.
ES8606362A1 (en) Antibacterial compounds.
EP0291799A3 (en) Dioxyalkylenearyl-dihydropyridines and their intermediary compounds, process for their preparation and their use
ES8802148A1 (en) Quinolonecarboxylic acid derivatives.
ES8503686A1 (en) Penicillin derivatives and process for preparation of the same.
ES8801230A1 (en) 1,5-Benzothiazephine derivatives, processes for preparing the same and pharmaceutical compositions.
ES8707541A1 (en) Cephalosporin derivatives.
ES2001341A6 (en) Novel guanidinomethylbenzoic acid derivatives.
ES8800240A1 (en) 3-pyrazolo(1,5-a)pyridinium cephem compounds, their production and use.
ES8601915A1 (en) Pyridazinones as beta-adrenoceptor antagonists.
ES8800122A1 (en) Indene and naphthalene derivatives.
ES8707217A1 (en) Novel 1,5-benzothiazepine derivative, processes for preparing the same and pharmaceutical compositions.
GR3030506T3 (en) 1-azaadamantane derivatives as 5-ht agonists or antagonists.
ES8502118A1 (en) Penicillin derivatives and process for preparation of the same.
MY102089A (en) Antibacterial compounds.
AU541530B2 (en) Derivatives of indolobenzoxazine
EP0312040A3 (en) 2,4-disubstituted derivatives of tetrahydrofuran
AU559732B2 (en) Di-and-tetrahydroguinolylacetic acid esters
ES480765A1 (en) 2-Guanidinomethyl-indolines, method for their preparation and their pharmaceutical use.
AU551901B2 (en) Substituted thienobenzodiazepinones
NO855383L (en) PROCEDURE FOR PIPERAZINE DERIVATIVES PREPARATION.
EP0160969A3 (en) Cephem compounds